Filing Details
- Accession Number:
- 0001395064-19-000083
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-22 06:23:03
- Reporting Period:
- 2019-10-08
- Accepted Time:
- 2019-11-22 06:23:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1636651 | Ovid Therapeutics Inc. | OVID | Pharmaceutical Preparations (2834) | DE |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1002637 | Millennium Pharmaceuticals Inc | 40 Landsdowne Street Cambridge MA 02139 | No | No | Yes | No | |
| 1395064 | Takeda Pharmaceutical Co Ltd | 1-1, Nihonbashi-Honcho 2-Chome Chuo-Ku, Tokyo M0 103-8668 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-10-08 | 2,000,000 | $2.50 | 5,750,000 | No | 4 | P | Indirect | See Explanation of Responses |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See Explanation of Responses |
Footnotes
- This statement is being filed jointly by Takeda Pharmaceutical Company Limited and Millennium Pharmaceuticals, Inc.
- Takeda Pharmaceutical Company Limited's beneficial ownership of the Issuer's Common Stock is comprised of 1,781,996 shares of Common Stock that it holds directly and 5,750,000 shares of Common Stock held directly by Millennium Pharmaceuticals, Inc., which is a direct, wholly owned subsidiary of Takeda Pharmaceuticals U.S.A. Inc., which is owned directly by both Takeda Pharmaceutical Company Limited (58.09%) and Takeda Pharmaceuticals International AG (41.91%). Takeda Pharmaceuticals International AG is a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.
Billionaire Hedge Funds
